Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
|
CN |
|
S
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd
SSE:600648
|
CN |
|
R
|
Resilux NV
LSE:0FSN
|
BE |
Luoxin Pharmaceuticals Group Stock Co Ltd
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 6,393 full-time employees. The company went IPO on 2016-04-15. The firm operates two segments. The Pharmaceutical Industry segment is engaged in the research and development, manufacturing and sales of chemical drug preparations and raw and auxiliary drugs. Its main products are digestive drugs, respiratory drugs and antibiotic drugs, among others. The Pharmaceutical Business segment is engaged in the sales and logistics of agent drugs and medical devices. The firm conducts its businesses in the domestic market.
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 6,393 full-time employees. The company went IPO on 2016-04-15. The firm operates two segments. The Pharmaceutical Industry segment is engaged in the research and development, manufacturing and sales of chemical drug preparations and raw and auxiliary drugs. Its main products are digestive drugs, respiratory drugs and antibiotic drugs, among others. The Pharmaceutical Business segment is engaged in the sales and logistics of agent drugs and medical devices. The firm conducts its businesses in the domestic market.
